Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic
NCT ID: NCT04438941
Last Updated: 2020-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-03-25
2020-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In view of the seriousness of the epidemic and the rapid arrival of new patients requiring mechanical ventilation, 3 new intensive care units have been created on the NHC site alone, making it possible to accommodate a maximum of 111 patients (compared to 52 during normal periods).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
French Single Centre Experience of Critically Ill Patients With Covid 19
NCT04354558
Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)
NCT04491214
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180
Impact of COVID19 Outbreak in Cardiac Acute Care
NCT04344912
Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
NCT03934112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient hospitalized in intensive care at the NHC, diagnosed COVID + and requiring a VD session of which at least one is performed by the dedicated team.
* patient who has not expressed, after information, his or her opposition to the re-use of his or her data for the purposes of this research
Exclusion Criteria
* Subject under guardianship, curatorship or safeguarding of justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7911
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.